Email updates

Keep up to date with the latest news and content from Diagnostic Pathology and BioMed Central.

Open Access Highly Accessed Research

High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma

Björn Nodin, Marie Fridberg, Liv Jonsson, Julia Bergman, Mathias Uhlén and Karin Jirström*

Diagnostic Pathology 2012, 7:82  doi:10.1186/1746-1596-7-82

Accesses  

  • Last 30 days: 59 accesses
  • Last 365 days: 881 accesses
  • All time: 2280 accesses

Cited by